
Jordi Ochando, PhD
About Me
Jordi Ochando, Ph.D. is an Assistant Professor of Oncological Sciences and Director of the Flow Cytometry CoRE at the Icahn School of Medicine at Mount Sinai. The Ochando laboratory investigates the origin, development, and immune function of macrophages in organ transplantation. His laboratory has recently discovered that trained immunity represents a previously unrecognized pathway that mediates allograft rejection. To prevent the detrimental effects of trained macrophages, the Ochando laboratory uses a novel revolutionary targeted therapeutic delivery approach in which drug-loaded nanobiologics that specifically target macrophages in vivo and induce long-term allograft acceptance. This research represents a compelling framework for developing novel targeted therapies that promote immunological tolerance.
Language
English
Position
ASSISTANT PROFESSOR | Medicine, Nephrology, ASSISTANT PROFESSOR | Oncological Sciences, ASSISTANT PROFESSOR | Immunology & Immunotherapy
Research Topics
Cancer, Dendritic Cells, Growth, Immunological Tolerance, Transplantation
Multi-Disciplinary Training Areas
Immunology [IMM]
Education
B.Sc., University of Alicante
Ph.D., De Montfort University
Publications
Selected Publications
- Myeloid-avid mammalian target of rapamycin-inhibiting nanobiologic attenuates allograft fibrosis after lung transplantation. Katsutaka Mineura, Charles R. Liu, Junedh M. Amrute, Shinichi Kawana, Fatima H. Elmenshawy, Jonathan L. Perez, Will Lounsbery-Scaife, Nikita Poddar, Venkatrao Nunna, Wenjun Li, Yuriko Terada, Austin Meadows, Gyu Seong Heo, William Wang, Maria Giulia Davighi, Judit Morla-Folch, Seokchan Park, Gabriel Laghlali, Eleanor Burgess, Michael Schotsaert, Yongjian Liu, Kory J. Lavine, Jon H. Ritter, Vibha N. Lama, Steven L. Brody, Ruben G. Nava, Andrew E. Gelman, Alexander S. Krupnick, Leticia Perez-Rodriguez, Dan Hasson, Abraham J.P. Teunissen, Jordi Ochando, Daniel Kreisel. American Journal of Transplantation
- Assessing the Willingness of Future Health Care Providers to Participate in Vaccine Trials: Cross-Sectional VACCELERATE European Study. Andreas Yiallouris, Charalampos Filippou, Christina Merakou, Christos D. Argyropoulos, Sophia C. Themistocleous, George Shiamakkides, Andreas Sarantopoulos, Ahmed Razi Shaikh, Evgenia Noula, Andria Nearchou, Elizabeth O. Johnson, Maria Papaconstantinou-Leontidou, Charis Armeftis, George Astras, Fiona A. Stewart, Kerstin Albus, Jon Salmanton-García, Janina Leckler, Anna Maria Azzini, Ruth Joanna Davis, Lenka Součková, Helena H. Askling, Tobias Lindström Battle, Elena Álvarez-Barco, Augustina Mozeryte, Dimitrios Poulimeneas, Ioannis Kopsidas, Jana Baranda Prellezo, Olena Valdenmaiier, Stine F. Jakobsen, Rebecca Jane Cox, Margot Hellemans, Greet Hendrickx, Pierre van Damme, Jordi Ochando, Theoklis E. Zaoutis, Ligita Jancoriene, Patrick Mallon, Pontus Nauclér, Petr Husa, Evelina Tacconelli, Oliver A. Cornely, Zoi Dorothea Pana. JMIR Public Health and Surveillance
- Systematic production of human kidney organoids for transplantation in porcine kidneys during ex vivo machine perfusion. Elena Garreta, Daniel Moya-Rull, Alberto Centeno, Andrés Marco, Asier Ullate-Agote, Gaia Amato, Carlos J. Aranda, Roger Oria, Daniel Lozano-Ojalvo, Merel B.F. Pool, Tim L. Hamelink, Idoia Lucía Selfa, Federico González, Carolina Tarantino, Alejandro Montero Salinas, Patricia López San Martín, Priyanka Koshy, Aleix Gavaldà-Navarro, Amaia Vilas-Zornoza, Juan R. Rodríguez-Madoz, Antón Fernández García, Inmaculada Marquez-Leiva, Henri G.D. Leuvenink, Cristobal Belda-Iniesta, Maarten Naesens, Beatriz Dominguez-Gil, Marcelino González-Martín, Javier Rodríguez-Rivera, Jordi Ochando, Felipe Prosper, Cyril Moers, Nuria Montserrat. Nature Biomedical Engineering
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Ochando did not report having any of the following types of financial relationships with industry and other outside entities during 2025 and/or 2026: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.